biild guided start-up healthcare company, Microbiosensor in turning its infection detection chemistries into commercially viable products.
Medical device use is one of the highest risk factors for patients contracting an infection. One particularly susceptible group are kidney dialysis patients, as the long term use of an invasive medical device increases their infection risk.
billd planned, created and delivered a development strategy to produce a ground-breaking device that provides an early warning system for infection in peritoneal dialysis patients. With a simple change of colour, the low-cost device promptly identifies an escalating infection.
The device enables nurses to intervene at the earliest opportunity. They can prevent or minimise the infection and subsequently reduce the requirement for hospitalisation. By using the device to identify the most appropriate antibiotic course, the risk of antibiotic resistance in peritoneal dialysis patients is reduced.